Literature DB >> 9766385

Angiotensin receptors in the nervous system.

A M Allen1, I Moeller, T A Jenkins, J Zhuo, G P Aldred, S Y Chai, F A Mendelsohn.   

Abstract

In addition to its traditional role as a circulating hormone, angiotensin is also involved in local functions through the activity of tissue renin-angiotensin systems that occur in many organs, including the brain. In the brain, both systemic and presumptive neurally derived angiotensin and angiotensin metabolites act through specific receptors to modulate many functions. This review examines the distribution of these specific angiotensin receptors and discusses evidence regarding the function of angiotensin peptides in various brain regions. Angiotensin AT1 and AT2 receptors occur in characteristic distributions that are highly correlated with the distribution of angiotensin-like immunoreactivity in nerve terminals. Acting through the AT1 receptor in the brain, angiotensin has effects on fluid and electrolyte homeostasis, neuroendocrine systems, autonomic pathways regulating cardiovascular function and behavior. Angiotensin AT1 receptors are also found in many afferent and efferent components of the peripheral autonomic nervous system. The role of the AT2 receptor in the brain is less well understood, although recent knockout studies point to an involvement with behavioral and cardiovascular functions. In addition to the AT1 and AT2 receptors, receptors for other fragments of angiotensin have been proposed. The AT4 binding site, which binds angiotensin, has a widespread distribution in the brain quite distinct from that of the AT1 and AT2 receptors. It is associated with many cholinergic neuronal groups and also several sensory nuclei, but its function remains to be determined. Our discovery that another brain-derived peptide binds to the AT4 binding site in the brain and may represent the native ligand is discussed. Overall, the distribution of angiotensin receptors in the brain indicate that they play diverse and important physiological roles in the nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766385     DOI: 10.1016/s0361-9230(98)00039-2

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  48 in total

Review 1.  Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla.

Authors:  Alan F Sved; Satoru Ito; Judith C Sved
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

2.  Exercise training prevents arterial baroreflex dysfunction in rats treated with central angiotensin II.

Authors:  Yan-Xia Pan; Lie Gao; Wei-Zhong Wang; Hong Zheng; Dongmei Liu; Kaushik P Patel; Irving H Zucker; Wei Wang
Journal:  Hypertension       Date:  2007-01-15       Impact factor: 10.190

3.  Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea.

Authors:  Ana Quenia Gomes da Silva; Marco Antônio Peliky Fontes; Nancy Lapp Kanagy
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

4.  Real-time imaging of the medullary circuitry involved in the generation of spontaneous muscle sympathetic nerve activity in awake subjects.

Authors:  Vaughan G Macefield; Luke A Henderson
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

5.  Direct evidence of intracrine angiotensin II signaling in neurons.

Authors:  Elena Deliu; G Cristina Brailoiu; Satoru Eguchi; Nicholas E Hoffman; Joseph E Rabinowitz; Douglas G Tilley; Muniswamy Madesh; Walter J Koch; Eugen Brailoiu
Journal:  Am J Physiol Cell Physiol       Date:  2014-01-08       Impact factor: 4.249

Review 6.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

7.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 8.  Effect of antihypertensive agents on quality of life in the elderly.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 9.  Rostral Ventrolateral Medulla and Hypertension.

Authors:  Patrice G Guyenet; Ruth L Stornetta; Benjamin B Holloway; George M P R Souza; Stephen B G Abbott
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

10.  Intracerebroventricular losartan infusion modulates angiotensin II type 1 receptor expression in the subfornical organ and drinking behaviour in bile-duct-ligated rats.

Authors:  Joseph D Walch; Flávia Regina Carreño; J Thomas Cunningham
Journal:  Exp Physiol       Date:  2012-12-13       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.